Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

Todd Neale

October 31, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

Topic 4: Pulmonary Hypertension and Device Choice

Presenter: Neil Fam

October 26, 2023

Presentation TCT 2023

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

Presenter: Daniel Burkhoff

October 25, 2023

Presentation TCT 2023

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

Presenter: Lucas Lauder

October 25, 2023

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Presentation TCT 2023

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Presenter: Ron miller

October 25, 2023

Presentation TCT 2023

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

Presenter: Tomasz Skowerski

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Presenter: NULL

October 25, 2023

Presentation TCT 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presenter: NULL

October 25, 2023

Presentation TCT 2023

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

Presenter: Hamza Naveed

October 25, 2023

Presentation TCT 2023

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Michel Azizi

October 25, 2023

Advertisement

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Topic 4: Pulmonary Hypertension and Device Choice

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

A High Standard of Clinical Evidence: Recent Key Milestones

TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis

TCT 398: Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Six-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content